Hans Biomed Overview
- Year Founded
-
1993
- Status
-
Public
- Employees
-
263
- Stock Symbol
-
042520
- Investments
-
2
- Share Price
-
$6.55
- (As of Friday Closing)
Hans Biomed General Information
Description
Hans Biomed Corp manufactures and markets bioengineering products. The company manufactures and sells skin and bone grafts for human transplantation, medical devices, silicone products, etc.
Contact Information
Website
www.hansbiomed.comCorporate Office
- 7, Jeongui-ro 8-gil, Songpa-gu
- Seoul, 05836
- South Korea
Corporate Office
- 7, Jeongui-ro 8-gil, Songpa-gu
- Seoul, 05836
- South Korea
Hans Biomed Stock Performance
As of 20-Jun-2025, Hans Biomed’s stock price is $6.55. Its current market cap is $85.1M with 13M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $6.55 | $6.52 | $4.15 - $9.14 | $85.1M | 13M | 28.2K | -$0.37 |
Hans Biomed Financials Summary
As of 31-Mar-2025, Hans Biomed has a trailing 12-month revenue of $60.5M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 30-Sep-2024 | FY 2023 30-Sep-2023 | FY 2022 30-Sep-2022 |
|---|---|---|---|---|
| EV | 82,035 | 119,889 | 179,486 | 95,644 |
| Revenue | 60,474 | 60,303 | 59,248 | 59,673 |
| EBITDA | 1,182 | 363 | (9,794) | 11,627 |
| Net Income | (4,747) | (5,368) | (17,497) | 4,926 |
| Total Assets | 87,397 | 92,820 | 90,653 | 92,034 |
| Total Debt | 29,356 | 27,781 | 30,478 | 39,074 |
Hans Biomed Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Hans Biomed Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Hans Biomed Patents
Hans Biomed Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4183369-A1 | Breast implant having waviness | Pending | 17-Jul-2020 | ||
| US-20230301771-A1 | Breast implant having waviness | Pending | 17-Jul-2020 | ||
| EP-4183369-A4 | Breast implant having waviness | Pending | 17-Jul-2020 | ||
| US-20220265279-A1 | Anchor for embolic coils, and embolic coil comprising same | Inactive | 17-Jul-2019 | ||
| ES-2644534-T3 | Medical suture with microdientes on the surface and procedure to manufacture it | Active | 24-Mar-2011 | D01D5/00 |
Hans Biomed Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Hans Biomed Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Hans Biomed Investments (2)
Hans Biomed’s most recent deal was a Joint Venture with Levos. The deal was made on 08-Jul-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Levos | 08-Jul-2022 | Joint Venture | Other Pharmaceuticals and Biotechnology | ||
| Atems | 01-Jul-2019 | Early Stage VC | Therapeutic Devices |
Hans Biomed FAQs
-
When was Hans Biomed founded?
Hans Biomed was founded in 1993.
-
Where is Hans Biomed headquartered?
Hans Biomed is headquartered in Seoul, South Korea.
-
What is the size of Hans Biomed?
Hans Biomed has 263 total employees.
-
What industry is Hans Biomed in?
Hans Biomed’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Hans Biomed a private or public company?
Hans Biomed is a Public company.
-
What is Hans Biomed’s stock symbol?
The ticker symbol for Hans Biomed is 042520.
-
What is the current stock price of Hans Biomed?
As of 20-Jun-2025 the stock price of Hans Biomed is $6.55.
-
What is the current market cap of Hans Biomed?
The current market capitalization of Hans Biomed is $85.1M.
-
What is Hans Biomed’s current revenue?
The trailing twelve month revenue for Hans Biomed is $60.5M.
-
What is Hans Biomed’s annual earnings per share (EPS)?
Hans Biomed’s EPS for 12 months was -$0.37.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
